Featured Job
-
Job Removed or Not Found
Related Jobs
- Legend Biotech USA, Inc. (Philadelphia, PA)
- …Lead and oversee all toxicology strategy and execution for preclinical development programs in cell and gene therapy.Design, implement, and interpret nonclinical safety
- Drax (Houston, TX)
- …We are Elimini and our purpose is to remove carbon for good. Why join Elimini? The Elimini team is on a mission to help rewind the climate crisis. The challenge we face
- Tris Pharma (Monmouth Junction, NJ)
- …We have >150 US and International patents and market several branded ADHD products in the US We also license our products in the US and ex-US markets. We have a robust
- Jobleads-US (Foster City, CA)
- …12 or more years of work experience with a Bachelor's Degree or at least 10 years of work experience with an Advanced degree (eg Masters/MBA /JD/MD), or a minimum of 5
- HP Inc. (Spring, TX)
- …+ **Define and Drive Product Vision & Strategy** Develop and own the multi-year product and portfolio strategy for HP's Core Workstation line, aligning it with
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …Reporting to the Sr. Director, Medical Affairs QA, the Director of Medical Affairs QA is responsible for providing strategic leadership and comprehensive quality
- Crane Aerospace & Electronics (Auburn, CA)
- …The Sr. Director of Operations is a key member of the leadership team whose peers include other CA&E Site Operations Directors as well as functional directors within
- Merck & Co. (North Wales, PA)
- …Bachelor's degree preferably in life sciences, technology, business operations. Required Experience: 12 years of experience in Clinical Trial Operations, Data Management
- Merck & Co. (Rahway, NJ)
- …and performance expectations.Promote individual and collective ownership of deliverables, driving results with a bias for action and a willingness to go above and beyond
- Formation Bio (New York, NY)
- …Develop and execute IP strategies that maximize asset value from in-licensing through exit Lead IP due diligence for pharmaceutical and biologic acquisitions, identifying